One Cell Foods (formerly Prosel Biosciences) is applying their proprietary technology to meet global demand for sustainable sourced, non-GMO, plant-based protein.

Mercury Bio (formerly Spartina Biotechnologies’) has developed patent-pending technology that will enable highly targeted delivery of both RNA therapeutics, and small-molecule drugs, to targeted diseased cells.

Bright Path Labs manufactures small molecules for life science companies. This agile and patented advanced pharmaceutical technology is paving the way for rapid, low-cost, and scalable domestic Advanced Pharmaceutical Ingredients (API) production.

Acoustic Biosystems develops blood sample preparation systems for improving clinical diagnostics at hospitals.

Cornerstone Innovation has developed a device to be used by anesthesiologists at Ambulatory Surgical Clinics (ASC) to improve the labeling of syringes and efficiency of regulatory compliance, such as recording the expiration and lot number of drugs administered.